The second generation HER2 CAR and mock lentiviral constructs have been described previously (Hammill et al., 2015; Helsen et al., 2018). The lentiviral vector encoding the anti-HER2 CAR consists of a human DARPin28z, a CD8 hinge region, a transmembrane and cytoplasmic domain of CD28, and the cytoplasmic region of CD3zeta (pCCL-Darpin-hCD8a NGFR) under the control of the human EF-1α promoter and truncated NGFR under the control of a human cytomegalovirus (hCMV) promoter as a transduction marker. The CAR negative control vector only includes the truncated NGFR gene under the hCMV promoter (pCCL-CMV-NGFR).
Third generation, self-inactivating and non-replicative lentivirus was produced as previously described (Hammill et al., 2016; Helsen et al., 2018). Briefly, 9 × 106 HEK 293T cells were first cultured on 15 cm diameter tissue culture-treated plates (NUNC; Thermo Fisher) until 70% confluency. The HEK 293T cells were then transfected with the packaging plasmids pRSV-REV (6.25 μg), pMD2.G (9 μg), pMDLg-pRRE (12.5 μg), and the transfer plasmid pCCL containing the transgene (32 μg) using Opti-MEM (Thermo Fisher) and Lipofectamine 2000 (Thermo Fisher). Twelve to sixteen hours after transfection, media was removed and supplemented with fresh HEK 293T media containing sodium butyrate (1mM; Sigma-Aldrich Canada Co.). After 36–48 hr post media replenishment, media containing lentivirus particles was collected, filtered with 0.45 μm filters and concentrated by ultracentrifugation (4°C, 1 hr 40min, 1.3 × 10 rcf). Viral pellet was resuspended in PBS (phosphate buffered saline) and stocks were stored at −80°C. Viral titer in TU/mL was determined by serial dilution and transduction of HEK 293T cells with thawed virus aliquots. Titer was determined by measuring the %NGFR positive population by flow cytometry using a VioBrightFITC-conjugated anti-NGFR antibody (Miltenyi Biotec).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.